<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862498</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1400</article-id><article-id pub-id-type="other">EPV0768</article-id><article-id pub-id-type="pii">S0924933824014007</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Quality of life in children and adolescents with beta thalassemia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tsagkou</surname><given-names>A.</given-names></name><xref rid="aff3093" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Evangelou</surname><given-names>E.</given-names></name><xref rid="aff3094" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vlachou</surname><given-names>E.</given-names></name><xref rid="aff3094" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zartaloudi</surname><given-names>A.</given-names></name><xref rid="aff3094" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor1250" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dousis</surname><given-names>E.</given-names></name><xref rid="aff3094" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dafogianni</surname><given-names>C.</given-names></name><xref rid="aff3094" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Polikandrioti</surname><given-names>M.</given-names></name><xref rid="aff3094" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Koutelekos</surname><given-names>I.</given-names></name><xref rid="aff3094" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff3093">
<sup>1</sup>
<institution>Greek Health System</institution>
</aff><aff id="aff3094"><sup>2</sup><institution>University of West Attica</institution>, <city>Athens</city>, <country>Greece</country></aff><author-notes><corresp id="cor1250"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1375">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S673</fpage><lpage>S674</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824014007a.pdf"/><abstract><sec id="sec7514"><title>Introduction</title><p>Children and adolescents with thalassemia suffer from chronicity of the disease and its treatment, including transfusion dependence and complications of iron overload.</p></sec><sec id="sec7515"><title>Objectives</title><p>To investigate the quality of life of children and adolescents with Beta Thalassaemia.</p></sec><sec id="sec7516"><title>Methods</title><p>This study is a cross-sectional study conducted at the Greek public Children&#x02019;s Hospital. PedsQL &#x02122; 4.0 Generic Core Scale (Greek version) was used to evaluate HRQOL in 41 thalassemia patients aged between 5 and 18 years and in 41 healthy controls of the same age range. For the analysis, the Statistic Package (SPSS ver.24) was used. Using Spearman&#x02019;s correlation coefficient, t-test and MannWhitney tests were used, while for variables with three or more levels the Anova and Kruskall-Wallis. In order to investigate the relationship between two quantitative variables, Spearman&#x02019;s correlation coefficient was used, while the relationship between two qualitative variables was used to control x2. As a statistical significance level, &#x003b1; = 5% was defined.</p></sec><sec id="sec7517"><title>Results</title><p>
Of the 41 children with beta Thalassemia who participated in the study, 48.8% (n = 20) were boys and 51.2% (n = 21) girls. The mean age of children was 10.02 &#x000b1; 4.10 years. For healthy children who participated in the study 51.2% (n = 21) were boys while 48.8% (n = 20) were girls. The mean age of the children was 9.63 &#x000b1; 3.77 years. Children with Beta Thalassaemia have a lower quality of life in Physical Health and Activity(&#x0003c;0,001), Emotional Health(0,031), School Activities(0,008), Psychosocial Health(0,014), and the overall PedsQL 4.0 (&#x0003c;0,001)questionnaire compared to healthy children. Children between the ages of 5 and 7 have higher levels of quality of life in physical health and activity than older children(&#x0003c;0,001). In addition, children aged 5 to 7 have higher quality of life and overall PedsQL 4.0 score than older children(0,033) Children receiving combination therapy show better quality of life than children receiving subcutaneous therapy (total PedsQL 4.0 &#x0003c;0,001).</p></sec><sec id="sec7518"><title>Conclusions</title><p>Children and adolescents in all five categories had a better quality of life, after improved iron chelating methods and other psychosocial interventions.</p></sec><sec id="sec7519"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>